Mulkerin Daniel L, Bergsbaken Jason J, Fischer Jessica A, Mulkerin Mary J, Bohler Aaron M, Mably Mary S
University of Wisconsin Carbone Cancer Center; UW Health, Madison, WI; and Riverside Health System, Newport News, VA.
J Oncol Pract. 2016 Oct;12(10):e912-e923. doi: 10.1200/JOP.2016.013748.
Use of oral chemotherapy is expanding and offers advantages while posing unique safety challenges. ASCO and the Oncology Nursing Society jointly published safety standards for administering chemotherapy that offer a framework for improving oral chemotherapy practice at the University of Wisconsin Carbone Cancer Center.
With the goal of improving safety, quality, and uniformity within our oral chemotherapy practice, we conducted a gap analysis comparing our practice against ASCO/Oncology Nursing Society guidelines. Areas for improvement were addressed by multidisciplinary workgroups that focused on education, workflows, and information technology. Recommendations and process changes included defining chemotherapy, standardizing patient and caregiver education, mandating the use of comprehensive electronic order sets, and standardizing documentation for dose modification. Revised processes allow pharmacists to review all orders for oral chemotherapy, and they support monitoring adherence and toxicity by using a library of scripted materials.
Between August 2015 and January 2016, revised processes were implemented across the University of Wisconsin Carbone Cancer Center clinics. The following are key performance indicators: 92.5% of oral chemotherapy orders (n = 1,216) were initiated within comprehensive electronic order sets (N = 1,315), 89.2% compliance with informed consent was achieved, 14.7% of orders (n = 193) required an average of 4.4 minutes review time by the pharmacist, and 100% compliance with first-cycle monitoring of adherence and toxicity was achieved.
We closed significant gaps between institutional practice and published standards for our oral chemotherapy practice and experienced steady improvement and sustainable performance in key metrics. We created an electronic definition of oral chemotherapies that allowed us to leverage our electronic health records. We believe our tools are broadly applicable.
口服化疗的应用正在扩大,它具有诸多优势,但也带来了独特的安全挑战。美国临床肿瘤学会(ASCO)和肿瘤护理学会联合发布了化疗给药安全标准,为威斯康星大学卡本癌症中心改善口服化疗实践提供了一个框架。
为了提高口服化疗实践中的安全性、质量和一致性,我们进行了差距分析,将我们的实践与ASCO/肿瘤护理学会的指南进行比较。多学科工作组针对改进领域展开工作,重点关注教育、工作流程和信息技术。建议和流程变更包括定义化疗、规范患者及护理人员教育、强制使用综合电子医嘱集以及规范剂量调整的文档记录。修订后的流程使药剂师能够审查所有口服化疗医嘱,并通过使用一系列书面材料库来支持对依从性和毒性的监测。
2015年8月至2016年1月期间,威斯康星大学卡本癌症中心的各个诊所实施了修订后的流程。以下是关键绩效指标:92.5%的口服化疗医嘱(n = 1216)在综合电子医嘱集中启动(N = 1315),知情同意的依从率达到89.2%,14.7%的医嘱(n = 193)平均需要药剂师4.4分钟的审查时间,并且在依从性和毒性的首次周期监测方面实现了100%的依从率。
我们缩小了机构实践与已发布的口服化疗实践标准之间的显著差距,并在关键指标上实现了稳步改进和可持续的表现。我们创建了口服化疗药物的电子定义,使我们能够利用电子健康记录。我们相信我们的工具具有广泛的适用性。